 |
|
Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex Keratitis
Fabiana P. Tambasco, MD;
Elisabeth J. Cohen, MD;
Lien H. Nguyen, MD;
Christopher J. Rapuano, MD;
Peter R. Laibson, MD
Arch Ophthalmol. 1999;117:445-449.
Objective To determine the efficacy of systemic acyclovir in decreasing complications and improving the outcome of penetrating keratoplasty for herpes simplex virus (HSV) keratitis.
Methods Retrospective study of 53 primary penetrating keratoplasties for HSV keratitis at an eye hospital from January 1, 1989, through December 31, 1996. Medical records were analyzed for history of HSV keratitis, preoperative neovascularization, and disease activity. Postoperative use of acyclovir, recurrence of HSV keratitis, rejection, uveitis or edema, and graft failure were evaluated.
Results Twenty-four patients (mean±SD follow-up, 44.7±32.6 months) received no acyclovir and were compared with 20 patients, (mean±SD follow-up, 28.8±16.7 months), who received 400 mg acyclovir twice a day for at least 1 year. No patient in the acyclovir group had a recurrence of dendritic keratitis in the first year compared with 5 (21%) of the patients who did not receive acyclovir (P=.03). No patient had graft failure in the acyclovir group compared with 4 (17%) in the group without acyclovir after 1 year of follow-up (P=.06).
Conclusion Postoperative systemic acyclovir therapy after penetrating keratoplasty for HSV keratitis is associated with a reduced rate of recurrent HSV dendritic keratitis and possible graft failure at 1 year of follow-up.
From the Cornea Service, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pa.
RELATED ARTICLE
Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 1999;117(4):555.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Penetrating keratoplasty: indications over a 10 year period
Al-Yousuf et al.
Br. J. Ophthalmol. 2004;88:998-1001.
ABSTRACT
| FULL TEXT
Long-term Acyclovir Use to Prevent Recurrent Ocular Herpes Simplex Virus Infection
Uchoa et al.
Arch Ophthalmol 2003;121:1702-1704.
ABSTRACT
| FULL TEXT
The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin
Halberstadt et al.
Br. J. Ophthalmol. 2002;86:646-652.
ABSTRACT
| FULL TEXT
Risk factors for graft infection in India: a case-control study
Vajpayee et al.
Br. J. Ophthalmol. 2002;86:261-265.
ABSTRACT
| FULL TEXT
Detection of herpes simplex virus type 1, 2 and varicella zoster virus DNA in recipient corneal buttons
van Gelderen et al.
Br. J. Ophthalmol. 2000;84:1238-1243.
ABSTRACT
| FULL TEXT
|
